To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 27 October 2025 to Question 77609 on Medical Treatments: Cost Effectiveness, if he will instruct NICE to review the adequacy of the Quality-Adjusted Life Year threshold fo
The pharmaceutical sector and the innovative medicines it produces are critical to our national interest, helping people access life changing treatments, reducing pressure on the health service over the longer-term, and ensuring we have a National Health ...
Medical Treatments: Cost Effectiveness